London
· Delayed Price · Currency is GBP · Price in EUR AlzChem Group AG Statistics
Total Valuation
AlzChem Group AG has a market cap or net worth of GBP 549.71 million. The enterprise value is 515.75 million.
| Market Cap | 549.71M |
| Enterprise Value | 515.75M |
Important Dates
The next estimated earnings date is Friday, February 28, 2025.
| Earnings Date | Feb 28, 2025 |
| Ex-Dividend Date | May 8, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 5.46M |
Valuation Ratios
The trailing PE ratio is 13.19.
| PE Ratio | 13.19 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 3.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.20, with an EV/FCF ratio of 7.51.
| EV / Earnings | 12.37 |
| EV / Sales | 1.09 |
| EV / EBITDA | 6.20 |
| EV / EBIT | 8.32 |
| EV / FCF | 7.51 |
Financial Position
The company has a current ratio of 2.32
| Current Ratio | 2.32 |
| Quick Ratio | 1.39 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 20.64 |
Financial Efficiency
Return on equity (ROE) is 28.41% and return on invested capital (ROIC) is 26.19%.
| Return on Equity (ROE) | 28.41% |
| Return on Assets (ROA) | 10.19% |
| Return on Invested Capital (ROIC) | 26.19% |
| Return on Capital Employed (ROCE) | 20.28% |
| Revenue Per Employee | 291,818 |
| Profits Per Employee | 25,942 |
| Employee Count | 1,708 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 1.85 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +153.58% in the last 52 weeks. The beta is 1.16, so AlzChem Group AG's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | +153.58% |
| 50-Day Moving Average | 60.41 |
| 200-Day Moving Average | 45.98 |
| Relative Strength Index (RSI) | 56.21 |
| Average Volume (20 Days) | 60,947 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AlzChem Group AG had revenue of GBP 468.95 million and earned 41.69 million in profits. Earnings per share was 4.10.
| Revenue | 468.95M |
| Gross Profit | 290.26M |
| Operating Income | 61.70M |
| Pretax Income | 58.17M |
| Net Income | 41.69M |
| EBITDA | 81.19M |
| EBIT | 61.70M |
| Earnings Per Share (EPS) | 4.10 |
Balance Sheet
| Cash & Cash Equivalents | 33.80M |
| Total Debt | n/a |
| Net Cash | 33.80M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 160.18M |
| Book Value Per Share | 15.74 |
| Working Capital | 126.22M |
Cash Flow
In the last 12 months, operating cash flow was 85.75 million and capital expenditures -17.11 million, giving a free cash flow of 68.65 million.
| Operating Cash Flow | 85.75M |
| Capital Expenditures | -17.11M |
| Free Cash Flow | 68.65M |
| FCF Per Share | n/a |
Margins
Gross margin is 61.90%, with operating and profit margins of 13.16% and 8.89%.
| Gross Margin | 61.90% |
| Operating Margin | 13.16% |
| Pretax Margin | 12.40% |
| Profit Margin | 8.89% |
| EBITDA Margin | 17.31% |
| EBIT Margin | 13.16% |
| FCF Margin | 14.64% |
Dividends & Yields
AlzChem Group AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | 12.86% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 24.38% |
| Buyback Yield | -0.03% |
| Shareholder Yield | -0.03% |
| Earnings Yield | 7.58% |
| FCF Yield | 12.49% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |